U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07217886) titled 'A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls' on Oct. 14.
Brief Summary: The purpose of this study is to measure the pharmacokinetics, safety, and tolerability of S-892216 (S-892216-PO) in participants with mild, moderate, or severe renal impairment not on dialysis, or renal impairment requiring hemodialysis (HD), and in participants with normal renal function.
Study Start Date: Oct. 17
Study Type: INTERVENTIONAL
Condition:
Renal Impairment
Intervention:
DRUG: S-892216-PO
S-892216-PO tablet will be administered orally.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shionogi
Published b...